Precision Medicine & Comprehensive Biomarker Testing: Using Patient-Tested Plain Language to Improve Communication with Your Patients

Webinars published on May 8, 2023
Claire Saxton
Vice President, Patient Experience
Cancer Support Community
Nikki Martin
Foundation Director, Precision Medicine Initiatives
LUNGevity

In collaboration with the Cancer Support Community, we are pleased to invite you to a webinar entitled “Precision Medicine & Comprehensive Biomarker Testing: Using Patient-Tested Plain Language to Improve Communication with Your Patients” presented by Claire Saxton, Cancer Support Community Vice President of Patient Experience and Nikki Martin, LUNGevity Foundation Director of Precision Medicine Initiatives.

Related Items
How to Explain Biomarker Testing to Patients
Claire Saxton
Video Library published on March 23, 2022 in Cancer Biomarkers, Precision Medicine
Claire Saxton, Vice President of Patient Experience, Cancer Support Community, says oncology professionals need to use clear and understandable language when discussing biomarker testing with the patients.
Standardized Terminology for Biomarker Testing
Claire Saxton
Video Library published on March 23, 2022 in Cancer Biomarkers, Precision Medicine
Discussion on precision medicine can be confusing without standardized terminology. Claire Saxton, Vice President of Patient Experience, Cancer Support Community, says cancer community and advocacy organizations have agreed on definitions of 3 standardized terms: biomarker testing, genetic testing for an inherited mutation, and genetic testing for inherited cancer risk.
How We Developed Terminology for Biomarker Testing
Claire Saxton
Video Library published on March 23, 2022 in Cancer Biomarkers, Precision Medicine
The Cancer Support Community engaged a group of oncology experts and a focus group to define 20 terms and concepts related to biomarker testing and precision medicine that are easy to understand for patients with cancer and their caregivers.